Investor Conference Business Updates, In Brief
Executive Summary
Amgen, Celgene, Mylan and Gilead were among the companies that provided business updates at the Cowen and Co. Healthcare conference and Raymond James Institutional Investors conference.
You may also be interested in...
Keeping Track: FDA Clears Celltrion's Biosimilar Inflectra; Review Activity In OIC Picks Up
The latest drug development news and highlights from our FDA Performance Tracker.
Keeping Track: Imbruvica Snags First-Line CLL Claim; Gilead TAF Strategy Advances
The latest drug development news and highlights from our FDA Performance Tracker.
CHMP Positive On Descovy, A Safer HIV Therapy?
Tenofovir alafenamide-based regimens could drive the growth of the anti-HIV market for next several years.